Skip to main content
logo
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
59.56
+2.71 (4.77%)
At close: May 20, 2026, 4:00 PM EDT
59.56
0.00 (0.00%)
After-hours: May 20, 2026, 4:10 PM EDT

Haemonetics Revenue

In the fiscal year ending March 28, 2026, Haemonetics had annual revenue of $1.33B, down -1.97%. Haemonetics had revenue of $346.35M in the quarter ending March 28, 2026, with 4.76% growth.

Revenue (ttm)
$1.33B
Revenue Growth
-1.97%
P/S Ratio
2.00
Revenue / Employee
$441,292
Employees
3,023
Market Cap
2.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 28, 20261.33B-26.79M-1.97%
Mar 29, 20251.36B51.76M3.95%
Mar 30, 20241.31B140.40M12.01%
Apr 1, 20231.17B175.46M17.67%
Apr 2, 2022993.20M122.73M14.10%
Apr 3, 2021870.46M-118.02M-11.94%
Mar 28, 2020988.48M20.90M2.16%
Mar 30, 2019967.58M63.66M7.04%
Mar 31, 2018903.92M17.81M2.01%
Apr 1, 2017886.12M-22.72M-2.50%
Apr 2, 2016908.83M-1.54M-0.17%
Mar 28, 2015910.37M-28.14M-3.00%
Mar 29, 2014938.51M46.52M5.22%
Mar 30, 2013891.99M164.15M22.55%
Mar 31, 2012727.84M51.15M7.56%
Apr 2, 2011676.69M31.26M4.84%
Apr 3, 2010645.43M47.55M7.95%
Mar 28, 2009597.88M81.44M15.77%
Mar 29, 2008516.44M66.83M14.86%
Mar 31, 2007449.61M29.87M7.12%
Apr 2, 2006419.73M36.14M9.42%
Apr 2, 2005383.60M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AdaptHealth3.29B
Integer Holdings1.86B
LivaNova1.43B
Neogen870.56M
iRhythm Holdings787.85M
NovoCure674.41M
TransMedics Group635.89M
UFP Technologies608.85M
Revenue Rankings

HAE News

More News